Showing results (111-120 of 190) with videos related to
Sort By:
Pageof 19
Cancer Research|June 1, 2014
Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancerPatricia A Thompson, Ingrid Ljuslinder, Spyros Tsavachidis, et al.Trials|September 12, 2020
Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)Kathrin Wode, Johanna Hök Nordberg, Gunver S Kienle, et al.Acta Oncologica (Stockholm, Sweden)|November 1, 2023
Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort studyKenny A Rodriguez-Wallberg, Johan Ahlgren, Karin E Smedby, et al.Scientific Reports|November 13, 2019
Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate modelAdrian Levitsky, Maria Pernemalm, Britt-Marie Bernhardson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2008
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)Roger Henriksson, Jacek Capala, Annika Michanek, et al.Neurology|June 17, 2020
Return to work following diagnosis of low-grade glioma: A nationwide matched cohort studyIsabelle Rydén, Louise Carstam, Sasha Gulati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancerJonas Bergh, Per-Ebbe Jönsson, Elisabet Kerstin Lidbrink, et al.Neuro-Oncology|June 24, 2024
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patientsMonika E Hegi, Felix B Oppong, James R Perry, et al.International Journal of Oncology|February 14, 2018
LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancerDavid Lindquist, Fernando C Alsina, Carl Herdenberg, et al.Plos One|December 14, 2012
EGFR gene variants are associated with specific somatic aberrations in gliomaCarl Wibom, Soma Ghasimi, Peter Van Loo, et al.Pageof 19